Krystal Biotech, Inc.
KRYS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001711279
In the last 90 days, Krystal Biotech, Inc. insiders filed 0 open-market purchases and 3 sales; 422 institutions reported holding it in 13F filings for Q2 2026, worth $11.1B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Krystal Biotech, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 137 | 1 | 148 | +12 |
| Shares | 20.8M | 4.51K | 20.8M | +35.1K (+0.2%) |
| Value | $1.36B | $296.0K | $1.45B | +$86.7M (+6.4%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Krystal Biotech, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 175,000 | $12.2M | 0.24% |
| Kennedy Capital Management, Inc. | 27,285 | $1.90M | 0.06% |
| Bank of Montreal | 21,638 | $1.55M | 0.00% |
| EFG Asset Management (North America) Corp. | 17,701 | $1.23M | 0.28% |
| Norges Bank | 13,526 | $942.8K | 0.00% |
| Tudor Investment Corp Et Al | 11,546 | $805.0K | 0.02% |
| Citadel Advisors LLC | 8,738 | $609.0K | 0.00% |
| Squarepoint Ops LLC | 8,320 | $580.0K | 0.01% |
| Occudo Quantitative Strategies LP | 6,703 | $467.0K | 0.04% |
| GWM Advisors LLC | 6,358 | $443.0K | 0.01% |
| Teacher Retirement System of Texas | 5,894 | $411.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 5,159 | $359.0K | 0.00% |
| Martingale Asset Management L P | 4,603 | $321.0K | 0.01% |
| Mariner, LLC | 4,009 | $279.0K | 0.00% |
| Ensign Peak Advisors, Inc | 3,670 | $256.0K | 0.00% |
| Almanack Investment Partners, LLC. | 732 | $52.0K | 0.01% |
| China Universal Asset Management Co., Ltd. | 240 | $17.0K | 0.01% |
| The PNC Financial Services Group, Inc. | 178 | $12.0K | 0.00% |
| Wipfli Financial Advisors LLC, | 106 | $7.00K | 0.00% |
| SJS Investment Consulting Inc. | 1 | $0 | 0.00% |
| Schubert & Co | 2 | $0 | 0.00% |
Sold out (9)
Institutions that held Krystal Biotech, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Atika Capital Management LLC | 30,000 | $1.97M |
| Millennium Management LLC | 15,076 | $990.0K |
| Jane Street Group, LLC | 4,509 | $296.0K |
| Sandia Investment Management LP | 4,194 | $275.0K |
| Captrust Financial Advisors | 155 | $10.0K |
| State of Wyoming | 69 | $5.00K |
| Cubist Systematic Strategies, LLC | 37 | $2.00K |
| Rockefeller Capital Management L.P. | 42 | $2.00K |
| Quadrant Capital Group LLC | 4 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held Krystal Biotech, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Taylor Wealth Management Partners | 4,514 | $296.0K |